Combination treatment of bortezomib and epirubicin increases the expression of TNFRSF10 A/B, and induces TRAIL-mediated cell death in colorectal cancer cells.

Autor:	Caldiran, Feyzanur1 (AUTHOR), Berkel, Caglar1 (AUTHOR), Yilmaz, Esra1 (AUTHOR), Kucuk, Burak1 (AUTHOR), Cacan, Aslihan Hatun2 (AUTHOR), Citli, Senol3 (AUTHOR), Canpolat, Emel1 (AUTHOR), Cacan, Ercan1 (AUTHOR) ercan.cacan@gop.edu.tr
Zdroj:	Biochemical & Biophysical Research Communications. Oct2023, Vol. 675, p33-40. 8p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect